{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:59:04Z","timestamp":1782773944233,"version":"3.54.5"},"reference-count":19,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.<\/jats:p>","DOI":"10.3390\/diagnostics9030084","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T03:06:58Z","timestamp":1564369618000},"page":"84","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5707-0689","authenticated-orcid":false,"given":"Carla","family":"Minoia","sequence":"first","affiliation":[{"name":"Haematology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"de Fazio","sequence":"additional","affiliation":[{"name":"Haematology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scognamillo","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Scattone","sequence":"additional","affiliation":[{"name":"Pathology Department, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maggialetti","sequence":"additional","affiliation":[{"name":"Radiodiagnostic Unit, Dipartmento di Medicina e Scienze della Salute \u201cVincenzo Tiberio\u201d, University of Molise, 86100 Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0168-8551","authenticated-orcid":false,"given":"Cristina","family":"Ferrari","sequence":"additional","affiliation":[{"name":"D.I.M.-Diagnostic Imaging-Nuclear Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Guarini","sequence":"additional","affiliation":[{"name":"Haematology Unit, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1200\/JCO.2008.17.3997","article-title":"Extramedullary myeloid sarcoma of the breast","volume":"26","author":"Azim","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1080\/10428190600967022","article-title":"A clinical review of breast involvement in acute leukemia","volume":"47","author":"Cunningham","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00277-003-0668-3","article-title":"Primary extramedullary myeloid tumor of the breast: A case report and review of the literature","volume":"82","author":"Fraga","year":"2003","journal-title":"Ann. Hematol."},{"key":"ref_6","first-page":"212","article-title":"Primary Myeloid Sarcoma of the Breast: A Case Report and Review of Literature","volume":"6","author":"Gomaa","year":"2018","journal-title":"J. Microsc. Ultrastruct."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/RLU.0b013e3181b53a6d","article-title":"F-18 FDG PET\/CT showing bilateral breast involvement in acute myeloid leukemia relapse","volume":"34","author":"Laenger","year":"2009","journal-title":"Clin. Nucl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.leukres.2016.12.003","article-title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","volume":"53","author":"Lazzarotto","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, J.G., Bae, J.H., Kim, J., Heo, K., Yang, K., and Yi, J.M. (2014). Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105405"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcb.24959","article-title":"Epigenetic DNA methylation in radiation biology: On the field or on the sidelines?","volume":"116","author":"Zielske","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/bmt.2011.210","article-title":"Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT","volume":"47","author":"Singh","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Modi, G., Madabhavi, I., Panchal, H., Patel, A., Anand, A., Parikh, S., Jain, P., Revannasiddaiah, S., and Sarkar, M. (2015). Primary vaginal myeloid sarcoma: A rare case report and review of the literature. Case Rep. Obstet. Gynecol., 957490.","DOI":"10.1155\/2015\/957490"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-016-2870-0","article-title":"Evidence for a role of decitabine in the treatment of myeloid sarcoma","volume":"96","author":"Gornicec","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12185-018-2470-y","article-title":"Activity of decitabine in pericardial myeloid sarcoma","volume":"108","author":"Evers","year":"2018","journal-title":"Int. J. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00277-018-3314-9","article-title":"Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: A case report","volume":"97","author":"Castelli","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/leu.2015.81","article-title":"Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41408-018-0083-6","article-title":"RTK-RAS pathway mutation is enriched in myeloid sarcoma","volume":"8","author":"Choi","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gil-Perez, A., and Montalban-Bravo, G. (2019). Management of myelodysplastic syndromes after failure of response to hypomethylating agents. Ther. Adv. Hematol.","DOI":"10.1177\/2040620719847059"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wong, K.K., Lawrie, C.H., and Green, T.M. (2019). Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia. Biomark. Insights.","DOI":"10.1177\/1177271919846454"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/9\/3\/84\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:10:18Z","timestamp":1760188218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/9\/3\/84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,27]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["diagnostics9030084"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics9030084","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,27]]}}}